( February 25, 2025, 2:52 PM EST) -- FORT WORTH, Texas — The U.S. Food and Drug Administration opposed a motion for a preliminary injunction filed by companies representing the interests of drug compounders that challenge the U.S. Food and Drug Administration’s decision to remove two FDA-approved drugs for diabetes and weight loss from the agency’s drug shortage list, arguing that the companies are unlikely to succeed in its suit against the agency....